InsiderTrades

Hicks Derek

SEC CIK 1901282 · EDGAR

Buying vs selling by month open-market trades, last 45 months, NTLA
BoughtSold

Companies

TickerCompanyTitleHoldingBoughtSoldTradesFirstLast
NTLAIntellia Therapeutics, Inc.EVP, Chief Business Off 59.9K — $260.8K 62022-01-032025-01-03

Most active insiders at NTLA, 12 months

#InsiderTitleBoughtSold
1 LEONARD JOHN MPres, CEO, Dir —$1.44M
2 Cohen Fred EDir $1.40M—
3 Dulac Edward J IIIEVP, CFO —$234.2K
4 BASTA JAMESEVP, GC —$112.4K
5 Lebwohl DavidEVP, Chief Medical Off —$109.6K
6 Dube Michael PVP, CAO —$104.4K
7 Clark ElianaEVP, Chief Technical Off —$96.0K
8 Schultes Birgit CEVP, CSO —$78.9K
9 Bhanji MunaDir ——
10 Keresty GeorgiaDir ——

Hicks Derek made no open-market trades at NTLA in the last 12 months.

Transactions 6

Type
Reset
X Filed Traded Ticker Company Insider Title Type Price Qty Owned ΔOwn Value
2025-01-07 2025-01-03 NTLA Intellia Therapeutics, Inc. Hicks Derek EVP, Chief Business Off S - Sale $12.18 -6,502 59.9K -10% -$79.2K
D 2024-03-05 2024-03-01 NTLA Intellia Therapeutics, Inc. Hicks Derek EVP, Chief Business Off A - Grant $0.00 +29.4K 66.4K +79% $0
2024-01-05 2024-01-03 NTLA Intellia Therapeutics, Inc. Hicks Derek EVP, Chief Business Off S - Sale $29.46 -3,877 37.0K -9% -$114.2K
D 2023-03-03 2023-03-01 NTLA Intellia Therapeutics, Inc. Hicks Derek EVP, Chief Business Off A - Grant $0.00 +23.6K 40.9K +136% $0
2023-01-06 2023-01-04 NTLA Intellia Therapeutics, Inc. Hicks Derek EVP, Chief Business Off S - Sale $37.21 -1,812 17.3K -9% -$67.4K
D 2022-01-05 2022-01-03 NTLA Intellia Therapeutics, Inc. Hicks Derek EVP, Chief Business Off A - Grant $0.00 +19.1K 19.1K New $0

Purchase Sale Sale after option exercise All abbreviations